Recombinant Luteinizing Hormone (rLH) Induces Ovarian Angiogenesis In Vivo via Modulation of the Expression of Follicular Vascular Endothelial Growth Factor (VEGF)-A165 and Its Soluble Receptor sFlt-1/VEGFR-1 but not Placental Growth Factor (PlGF). A Prospective, Randomized, Double-Blind, Placebo-Controlled Study

Saved in:
Bibliographic Details
Published inFertility and sterility Vol. 84; pp. S315 - S316
Main Authors Gutman, G., Barak, V., Maslovitz, S., Amit, A., Lessing, J.B., Geva, E.
Format Journal Article
LanguageEnglish
Published 01.09.2005
Online AccessGet full text

Cover

More Information
ISSN:0015-0282
DOI:10.1016/j.fertnstert.2005.07.825